{"id":2243,"date":"2013-11-01T12:04:00","date_gmt":"2013-11-01T11:04:00","guid":{"rendered":"https:\/\/der-arzneimittelbrief.com\/artikel\/2013\/purin-analoga-in-der-therapie-der-colitis-ulcerosa-und-das-risiko-fuer-lymphome"},"modified":"2013-11-01T12:04:00","modified_gmt":"2013-11-01T11:04:00","slug":"purin-analoga-in-der-therapie-der-colitis-ulcerosa-und-das-risiko-fuer-lymphome","status":"publish","type":"post","link":"https:\/\/der-arzneimittelbrief.com\/artikel\/2013\/purin-analoga-in-der-therapie-der-colitis-ulcerosa-und-das-risiko-fuer-lymphome","title":{"rendered":"Purin-Analoga in der Therapie der Colitis ulcerosa und das Risiko f\u00fcr Lymphome"},"content":{"rendered":"<p>Patienten mit Colitis ulcerosa (CU) erhalten als Bestandteil der Erhaltungstherapie h\u00e4ufig Purin-Analoga (PA) wie Azathioprin (Imurek\u00ae, Generika), 6-Thioguanin oder 6-Mercaptopurin (Puri-Nethol\u00ae, Generika). Schon seit l\u00e4ngerer Zeit gibt es die Bef\u00fcrchtung, dass Chronisch entz\u00fcndliche Darmerkrankungen (CED) selbst oder die Therapie dieser Erkrankungen das Risiko f\u00fcr Lymphome erh\u00f6hen k\u00f6nnten. Durch anhaltende Immunsuppression im Rahmen der Therapie k\u00f6nnte [&hellip;]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Patienten mit Colitis ulcerosa (CU) erhalten als Bestandteil der Erhaltungstherapie h\u00e4ufig Purin-Analoga (PA) wie Azathioprin (Imurek\u00ae, Generika), 6-Thioguanin oder 6-Mercaptopurin (Puri-Nethol\u00ae, Generika). Schon seit l\u00e4ngerer Zeit gibt es die Bef\u00fcrchtung, dass Chronisch entz\u00fcndliche Darmerkrankungen (CED) selbst oder die Therapie dieser Erkrankungen das Risiko f\u00fcr Lymphome erh\u00f6hen k\u00f6nnten. Durch anhaltende Immunsuppression im Rahmen der Therapie k\u00f6nnte [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[2443,2157,239,4490,1188,2514,1959],"class_list":["post-2243","post","type-post","status-publish","format-standard","hentry","category-allgemein","tag-6-mercaptopurin","tag-6-thioguanin","tag-azathioprin","tag-cesame-studie","tag-colitis-ulcerosa","tag-lymphome","tag-purin-analoga"],"_links":{"self":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/2243","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/comments?post=2243"}],"version-history":[{"count":0,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/2243\/revisions"}],"wp:attachment":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/media?parent=2243"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/categories?post=2243"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/tags?post=2243"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}